NTAP vs TVRD · P/E 28, rev $6.24B vs rev $2.6M
NetApp Inc (NTAP) versus Tvardi Therapeutics, Inc. (TVRD) — a side-by-side from cached financials, not a winner call.
NetApp Inc (NTAP) is a software - infrastructure company listed on US.
Tvardi Therapeutics, Inc. (TVRD) is a biotechnology company listed on US.
Latest reported NTAP revenue for 2026-04-24 was $6.24B. Net income was $1.28B. Revenue was down 5.1% from 2025-04-25 to 2026-04-24. NTAP currently screens at market cap $35.43B and trailing P/E 28.2.
Latest reported TVRD revenue for 2025-03-31 was $2.6M. Net income was -$4.9M. TVRD currently screens at market cap $0.
NTAP currently screens at market cap $35.43B and trailing P/E 28.2. TVRD currently screens at market cap $0.
Not investment advice. Open the NTAP and TVRD stock pages for the full models.
Not investment advice.